CryoCell Days Payables Outstanding from 2010 to 2025

CCEL Stock  USD 5.43  0.10  1.81%   
CryoCell International Days Payables Outstanding yearly trend continues to be quite stable with very little volatility. The value of Days Payables Outstanding is projected to decrease to 98.04. From the period between 2010 and 2025, CryoCell International, Days Payables Outstanding regression line of its data series had standard deviation of  26.91 and standard deviation of  26.91. View All Fundamentals
 
Days Payables Outstanding  
First Reported
2010-12-31
Previous Quarter
99.41
Current Value
98.04
Quarterly Volatility
26.90802411
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CryoCell International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CryoCell International's main balance sheet or income statement drivers, such as Depreciation And Amortization of 687.1 K, Selling General Administrative of 11.5 M or Total Revenue of 18.9 M, as well as many indicators such as Price To Sales Ratio of 2.41, Dividend Yield of 0.0245 or Days Sales Outstanding of 79.26. CryoCell financial statements analysis is a perfect complement when working with CryoCell International Valuation or Volatility modules.
  
Check out the analysis of CryoCell International Correlation against competitors.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.

Latest CryoCell International's Days Payables Outstanding Growth Pattern

Below is the plot of the Days Payables Outstanding of CryoCell International over the last few years. It is CryoCell International's Days Payables Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CryoCell International's overall financial position and show how it may be relating to other accounts over time.
Days Payables Outstanding10 Years Trend
Very volatile
   Days Payables Outstanding   
       Timeline  

CryoCell Days Payables Outstanding Regression Statistics

Arithmetic Mean83.20
Geometric Mean78.83
Coefficient Of Variation32.34
Mean Deviation21.13
Median86.44
Standard Deviation26.91
Sample Variance724.04
Range101
R-Value(0.01)
Mean Square Error775.66
R-Squared0.0001
Significance0.97
Slope(0.06)
Total Sum of Squares10,861

CryoCell Days Payables Outstanding History

2025 98.04
2024 99.41
2023 86.44
2022 137.25
2021 66.64
2020 60.49
2019 36.18

About CryoCell International Financial Statements

CryoCell International investors utilize fundamental indicators, such as Days Payables Outstanding, to predict how CryoCell Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Days Payables Outstanding 99.41  98.04 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports:
Check out the analysis of CryoCell International Correlation against competitors.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.625
Dividend Share
0.25
Earnings Share
0.05
Revenue Per Share
3.934
Quarterly Revenue Growth
0.019
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.